You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

CLINICAL TRIALS PROFILE FOR TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01949337 ↗	Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer	Active, not recruiting	Astellas Pharma US, Inc.	Phase 3	2014-01-22	This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the amount of androgens made by the body.
NCT01949337 ↗	Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer	Active, not recruiting	Biologics, Inc.	Phase 3	2014-01-22	This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the amount of androgens made by the body.
NCT01949337 ↗	Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer	Active, not recruiting	Medivation, Inc.	Phase 3	2014-01-22	This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate cancer cells. Drugs, such as enzalutamide, abiraterone acetate, and prednisone, may lessen the amount of androgens made by the body.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

Condition Name

Chart
Table

Condition Name for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Intervention	Trials
Adenocarcinoma of the Prostate	1
Arthritis, Psoriatic	1
Differentiated Thyroid Cancer	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Intervention	Trials
Prostatic Neoplasms	1
Adenocarcinoma	1
Arthritis, Psoriatic	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

Trials by Country

Map
Table

Trials by Country for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Location	Trials
United States	49
Canada	6
China	2
Puerto Rico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Location	Trials
Minnesota	1
Michigan	1
Massachusetts	1
Maryland	1
Maine	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Clinical Trial Phase	Trials
Completed	2
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT

Sponsor Name

Chart
Table

Sponsor Name for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Sponsor	Trials
Astellas Pharma US, Inc.	1
Biologics, Inc.	1
Medivation, Inc.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT
Sponsor	Trials
Other	4
Industry	3
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.